Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017

Objectives To detect the signals for drospirenone-containing oral contraceptives (DCOCs) and describe the reporting pattern of adverse events (AEs) caused by DCOCs compared with levonorgestrel/desogestrel/gestodene-containing (second/third generation) oral contraceptives.Design A descriptive analysi...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Ha-Lim Jeon, Ju-Young Shin, Seung-Ah Choe, Yeri Lee, Ahhyung Choi, Yunha Noh
Format: Artykuł
Język:English
Wydane: BMJ Publishing Group 2021-08-01
Seria:BMJ Open
Dostęp online:https://bmjopen.bmj.com/content/11/8/e045948.full
_version_ 1826945367837507584
author Ha-Lim Jeon
Ju-Young Shin
Seung-Ah Choe
Yeri Lee
Ahhyung Choi
Yunha Noh
author_facet Ha-Lim Jeon
Ju-Young Shin
Seung-Ah Choe
Yeri Lee
Ahhyung Choi
Yunha Noh
author_sort Ha-Lim Jeon
collection DOAJ
description Objectives To detect the signals for drospirenone-containing oral contraceptives (DCOCs) and describe the reporting pattern of adverse events (AEs) caused by DCOCs compared with levonorgestrel/desogestrel/gestodene-containing (second/third generation) oral contraceptives.Design A descriptive analysis of claims data.Setting The Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System Database from 1 February 2008 to 31 December 2017.Outcome measures Signals for DCOCs were identified using three data mining indices. The characteristics, death cases, and the annual pattern of AE reports were compared between DCOCs and second/third generation oral contraceptives.Results Of the 242 DCOC-related AEs, 54 signals were detected and 10 were identified as new signals that were not included in Korea, US and UK label. The newly detected signals include deep vein thrombophlebitis and frequent urination. Serious AEs were more likely to be reported with DCOCs (7.85%) than with second/third generation oral contraceptives (2.92%). Five deaths after use of DCOCs were reported with vascular AEs, such as pulmonary embolism and thrombosis, whereas one death after use of second/third generation oral contraceptives was reported with the cardiac arrest.Conclusions We identified 10 new signals related to DCOCs that were not included in the current label. Additionally, we found higher reports of the deaths and vascular AEs associated with DCOCs than with second/third generation oral contraceptives, which warrants careful monitoring to ensure the safe use of DCOCs.
first_indexed 2025-02-17T20:53:55Z
format Article
id doaj.art-0cf3a901b9ee45daa1af2fa68c54a01a
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2025-02-17T20:53:55Z
publishDate 2021-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-0cf3a901b9ee45daa1af2fa68c54a01a2024-12-09T04:20:09ZengBMJ Publishing GroupBMJ Open2044-60552021-08-0111810.1136/bmjopen-2020-045948Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017Ha-Lim Jeon0Ju-Young Shin1Seung-Ah Choe2Yeri Lee3Ahhyung Choi4Yunha Noh5School of Pharmacy, Sungkyunkwan University, Suwon, Korea (the Republic of)School of Pharmacy, Sungkyunkwan University, Suwon, Korea (the Republic of)Korea University - Anam Campus, Seongbuk-gu, Korea (the Republic of)School of Pharmacy, Sungkyunkwan University, Suwon, Korea (the Republic of)School of Pharmacy, Sungkyunkwan University, Suwon, Korea (the Republic of)School of Pharmacy, Sungkyunkwan University, Suwon, Korea (the Republic of)Objectives To detect the signals for drospirenone-containing oral contraceptives (DCOCs) and describe the reporting pattern of adverse events (AEs) caused by DCOCs compared with levonorgestrel/desogestrel/gestodene-containing (second/third generation) oral contraceptives.Design A descriptive analysis of claims data.Setting The Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System Database from 1 February 2008 to 31 December 2017.Outcome measures Signals for DCOCs were identified using three data mining indices. The characteristics, death cases, and the annual pattern of AE reports were compared between DCOCs and second/third generation oral contraceptives.Results Of the 242 DCOC-related AEs, 54 signals were detected and 10 were identified as new signals that were not included in Korea, US and UK label. The newly detected signals include deep vein thrombophlebitis and frequent urination. Serious AEs were more likely to be reported with DCOCs (7.85%) than with second/third generation oral contraceptives (2.92%). Five deaths after use of DCOCs were reported with vascular AEs, such as pulmonary embolism and thrombosis, whereas one death after use of second/third generation oral contraceptives was reported with the cardiac arrest.Conclusions We identified 10 new signals related to DCOCs that were not included in the current label. Additionally, we found higher reports of the deaths and vascular AEs associated with DCOCs than with second/third generation oral contraceptives, which warrants careful monitoring to ensure the safe use of DCOCs.https://bmjopen.bmj.com/content/11/8/e045948.full
spellingShingle Ha-Lim Jeon
Ju-Young Shin
Seung-Ah Choe
Yeri Lee
Ahhyung Choi
Yunha Noh
Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
BMJ Open
title Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
title_full Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
title_fullStr Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
title_full_unstemmed Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
title_short Signal detection of drospirenone-containing oral contraceptives: a disproportionality analysis using the Korea Adverse Event Reporting System Database, 2008–2017
title_sort signal detection of drospirenone containing oral contraceptives a disproportionality analysis using the korea adverse event reporting system database 2008 2017
url https://bmjopen.bmj.com/content/11/8/e045948.full
work_keys_str_mv AT halimjeon signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017
AT juyoungshin signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017
AT seungahchoe signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017
AT yerilee signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017
AT ahhyungchoi signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017
AT yunhanoh signaldetectionofdrospirenonecontainingoralcontraceptivesadisproportionalityanalysisusingthekoreaadverseeventreportingsystemdatabase20082017